Assessment of Biliary Clearance in Early Drug Discovery Using Sandwich-Cultured Hepatocyte Model
文献类型：期刊论文
| 作者 | Pan, Guoyu2 ; Boiselle, Carri1; Wang, Jianling1
|
| 刊名 | JOURNAL OF PHARMACEUTICAL SCIENCES
 |
| 出版日期 | 2012-05 |
| 卷号 | 101期号:5页码:1898-1908 |
| 关键词 | biliary excretion hepatobiliary disposition drug interactions in vitro-in vivo correlations (IVIVC) hepatic clearance permeability transporters hepatocytes |
| ISSN号 | 0022-3549 |
| DOI | 10.1002/jps.23070 |
| 文献子类 | Article |
| 英文摘要 | It is challenging to predict biliary clearance (CLb) for new chemical entities (NCEs) in early drug discovery. Although sandwich-cultured hepatocyte (SCH) model has offered a valuable tool for characterizing hepatobiliary disposition and drug-drug interaction potential of NCEs, no comprehensive study was reported to project in vivo biliary clearance (in vivo CLb,(observed)) potential using in vitro SCH model during the drug discovery stage. In this study, the CLb of 110 discovery compounds was evaluated using rat SCH model. Parallel artificial membrane permeability assay, Caco-2, and rat liver microsomes were employed in parallel to explore the interplay of biliary excretion with cellular permeability and liver metabolism. Selected compounds were further tested in bile-duct-cannulated rats, confirming the value of the SCH model for ranking and predicting in vivo CLb,(observed) during drug discovery. For compounds with extremely low passive permeability and metabolism, rat SCH may underestimate in vivo CLb,(observed). The combination of passive permeability, metabolic intrinsic clearance, and the SCH model could serve as an initial screening platform for biliary excretion potential as well as a means for improving compound liabilities and properties. A preliminary evaluation strategy was proposed to highlight biliary excretion risk evaluation during the drug discovery process. (C) 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101: 1898-1908, 2012 |
| WOS关键词 | PLASMA-PROTEIN BINDING ; ORGANIC ANION TRANSPORTER ; IN-VIVO CORRELATION ; RAT HEPATOCYTES ; PHYSICOCHEMICAL PROPERTIES ; HEPATOBILIARY TRANSPORT ; P-GLYCOPROTEIN ; LONG-TERM ; EXCRETION ; EXPRESSION |
| WOS研究方向 | Pharmacology & Pharmacy ; Chemistry |
| 语种 | 英语 |
| WOS记录号 | WOS:000302800100025 |
| 出版者 | WILEY-BLACKWELL |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/278103]  |
| 专题 | 药物安全性评价中心 |
| 通讯作者 | Pan, Guoyu |
| 作者单位 | 1.Novartis Inst Biomed Res, Cambridge, MA 02139 USA 2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, Shanghai 200031, Peoples R China; |
| 推荐引用方式 GB/T 7714 | Pan, Guoyu,Boiselle, Carri,Wang, Jianling. Assessment of Biliary Clearance in Early Drug Discovery Using Sandwich-Cultured Hepatocyte Model[J]. JOURNAL OF PHARMACEUTICAL SCIENCES,2012,101(5):1898-1908. |
| APA | Pan, Guoyu,Boiselle, Carri,&Wang, Jianling.(2012).Assessment of Biliary Clearance in Early Drug Discovery Using Sandwich-Cultured Hepatocyte Model.JOURNAL OF PHARMACEUTICAL SCIENCES,101(5),1898-1908. |
| MLA | Pan, Guoyu,et al."Assessment of Biliary Clearance in Early Drug Discovery Using Sandwich-Cultured Hepatocyte Model".JOURNAL OF PHARMACEUTICAL SCIENCES 101.5(2012):1898-1908. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。